Silo Pharma, Inc. Net Income Loss

• Silo Pharma, Inc. showed an increase of +3.8% in Net Income Loss from 2024 to 2025.
• This data is from Silo Pharma, Inc.'s annual report (Form 10-K), filed with the SEC on March 27, 2026.
• XBRL data for this metric is available from 2011 to 2025 (11 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
• Over the full 11 years of available data (2011 to 2025), Silo Pharma, Inc.'s Net Income Loss has declined by 8,388.8%.
• Historical annual values: Fiscal year 2025: -$4.23 million | Fiscal year 2024: -$4.39 million | Fiscal year 2023: -$3.70 million | Fiscal year 2022: -$3.91 million | Fiscal year 2021: $3.90 million | Fiscal year 2020: -$3.04 million | Fiscal year 2019: -$1.01 million | Fiscal year 2018: -$969.5 thousand | Fiscal year 2017: $356.5 thousand | Fiscal year 2012: -$39.4 thousand | Fiscal year 2011: -$49.8 thousand.
• Data sourced from SEC EDGAR public filings as of June 23, 2026.

Last verified: June 23, 2026